Laboratory tests show CPTQ significantly inhibits S. mutans growth, highlighting its dual antibacterial mechanisms and potential in dental care.
Dental caries, primarily caused by Streptococcus mutans (S. mutans) biofilms, remains a global health concern. Antimicrobial photodynamic therapy (aPDT) has shown promise in controlling cariogenic bacteria by generating reactive oxygen species (ROS), but the aggregation-caused quenching (ACQ) effect of traditional photosensitizers limits its efficacy. In this study, we developed a novel aggregation-induced emission (AIE) photosensitizer, CPTQ, with an enhanced photodynamic antibacterial efficacy and intrinsic antibacterial properties. CPTQ exhibited superior ROS generation, effective bacterial labeling, and strong membrane anchoring, leading to a significant disruption of bacterial membrane homeostasis and interference with bacterial metabolism. Moreover, CPTQ induced ferroptosis-like bacterial death by triggering lipid peroxidation and oxidative stress, providing a synergistic antibacterial strategy. In vitro results demonstrated that CPTQ effectively inhibited S. mutans growth, while in vivo studies in a rat dental caries model showed significant reductions in cariogenic bacterial load and caries progression. Given its excellent biocompatibility and dual antibacterial mechanisms, CPTQ offers a promising and innovative strategy for the prevention and treatment of dental caries.
No takes yet. Share an insight, caveat, or question.
Li et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: